Project Grant R01HL179350
- Federal Grant Award Summary Vanderbilt University received a $489,644 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with completion targeted for July 31, 2027. The project aims to develop novel drug-coated balloon (DCB) therapies using peptide-based delivery mechanisms to improve long-term vessel patency following angioplasty in peripheral arterial disease (PAD) treatment....
- Federal Project Grant Award Summary Vanderbilt University Medical Center received $874,997 in federal funding from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) for a project grant awarded on September 15, 2025, with completion targeted by August 31, 2026. The project delivers a prospective clinical trial evaluating personalized oxygen therapy targets for mechanically ventilated critically ill adults. The research applies...
- Federal Grant Award Summary Vanderbilt University Medical Center received a $185,720 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded September 1, 2025, with a completion date of August 31, 2030. This award supports Dr. Stephanie DeMasi's clinical research initiative investigating the use of sedation-only intubation protocols to prevent hypoxemia during emergency tracheal intubation in critically...
- Federal Grant Award Summary Vanderbilt University received a $753,327 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded June 15, 2026, with a completion date of March 31, 2030. The award funds research investigating membrane lipid asymmetry in cardiometabolic disease, specifically examining how genetic variants in the ATP10A and ATP10D genes contribute to dyslipidemia, endothelial dysfunction, and...
- Federal Project Grant Award Summary Georgia Tech Research Corporation received a $709,172 Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), effective September 1, 2025, through June 30, 2030. The award supports the development and validation of improved three-dimensional (3D) printed airway splints designed to treat tracheobronchomalacia (TBM), a congenital or acquired airway condition causing dynamic airway...
- Federal Project Grant Summary Vanderbilt University, through its Sponsored Programs Administration division, received a $423,142 Project Grant from the National Institute on Aging (CFDA 93.866—Aging Research) awarded May 1, 2026, with an ultimate completion date of April 30, 2028. The grant supports development of a novel esophageal stent integrated with wirelessly actuated magnetic undulating sheets designed to restore peristalsis in patients with esophageal dysmotility, particularly those with...
- Federal Grant Award Summary Award Details: The National Heart, Lung, and Blood Institute (NHLBI) awarded Vanderbilt University Medical Center a Project Grant in the amount of $2.59 million under the Cardiovascular Diseases Research program (CFDA 93.837) for research titled "The Contribution of Superoxide Influx via LRRC8 Anion Channels to Infectious Vascular Dysfunction." The award was obligated on May 15, 2026, with an ultimate completion date of February 29, 2028, and is being...
- Federal Project Grant Award Summary Vesteck, Inc. received a $1.36M Project Grant from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837), awarded on September 15, 2025, with completion targeted for May 31, 2027. The award supports development and advancement of an endovascular suturing device designed to augment endograft fixation during endovascular repair (EVAR) of abdominal aortic aneurysms (AAA). The device addresses a...
- Federal Project Grant Award Summary Vanderbilt University Medical Center received a $811,370 Project Grant award effective September 1, 2025, through August 31, 2030, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837). The research investigates how YAP and TAZ, key regulatory proteins in the Hippo signaling pathway, control alveolar epithelial cell regeneration during lung repair and recovery. The project addresses critical...
- Federal Grant Award Summary The National Heart, Lung, and Blood Institute (NHLBI) awarded Vanderbilt University Medical Center a $170,640 Project Grant (CFDA 93.837: Cardiovascular Diseases Research) on September 19, 2025, with completion targeted for August 31, 2030. This K08 Career Development Award supports a five-year research and training initiative led by Dr. Niedermeyer under the mentorship of Dr. Larissa Shimoda and Dr. Mahendra Damarla. The grant funds both scientific investigation into...
Vanderbilt University received a $577,334 Project Grant award dated July 9, 2026, from the National Heart, Lung, and Blood Institute (NHLBI) under the Cardiovascular Diseases Research program (CFDA 93.837) to develop a Sensory Airway Stent (SAS). The project, which extends through April 30, 2031, centers on designing and fabricating an innovative airway stent integrated with flexible sensors and a wearable magnetic actuation system capable of continuously monitoring stent patency and airway conditions in patients with central airway obstruction caused by lung cancer and other diseases. The core deliverables include an optimized sensor-integrated airway stent that mimics biological ciliary sensing functions to measure mucus viscosity and layer thickness, coupled with a novel wearable magnetic actuation and remote powering system for long-term external monitoring. This technology aims to reduce the clinical burden of invasive monitoring procedures such as bronchoscopy while enabling real-time assessment of airway health conditions. The research leverages the principal investigator's prior expertise in actuation-enhanced sensing mechanisms, smart airway stents, and magnetic actuation systems to address critical gaps in current monitoring methods that rely on ultrasound imaging, computed tomography, or invasive endoscopic procedures.Federal Grant Award Summary
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | $577.3k | 7/14/26 |